Skip to content

Dr. Imke Bytebier

Active
Private limited companyfounded 20232 yrs activeVremdesesteenweg 261, 2531 Boechout, BelgiumKBO/BCE: BE 1002.495.889
Summary

Dr. Imke Bytebier has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €93,233 and a net result of €43,042. Its solvency ranks better than 24% of 17112 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

What they do
General medical practice
NACE 86210
1 site
How big
€332,199total assets 2025
Equity
€93,233
Profit
€43,042
Turnover not published (abridged schema)
Financially healthy?
75 Excellent Checked score 2025
Bankruptcy chance 12 m
0.2%
Who decides
Accounts filed 31 d late0 of 1 deed read
Why 75- Young company- Weak solvency vs sector+ Lower-failure-rate sector+ Annual accounts: healthy financial profileFiled after the deadlineShow the evidence

Checked score

Score 2025
Axes · tick = 2024
Profitability85▼-3
Solvency53▲+11
Growth52
Track record82
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €6,000 at 30 days only on tighter terms
Liquidity short (current ratio 0.69 against 0.38 in 2024; short-term debt: 71.7% and cash: 44.7% of total assets), and 71.9% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
28.1%
Return on assets
13%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 24% of 17112 sector peers (2025).
NBB · sector comparison
Position among 17112 sector peers
Solvency
better than 24%
← weakest strongest →
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 2 filings
Deviation from the deadline
2025
31 d late
2024
29 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 30 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
01-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · micro…
  2. Annual accounts filedfiscal year 2024 · micro…

Financials

Fiscal year 2025Total assets €332,199Profit €43,042Solvency 28.1%Liquidity 0.69
Total assets
€332,199▲ 12.7%
2024 - 2025
Net result
€43,042▼ 4.8%
2024 - 2025
Equity
€93,233▲ 85.8%
2024 - 2025
Solvency
28.1%▲ 11.0pp
2024 - 2025

Financials · fiscal year 2025, micro schema

Trend over the years2 fiscal years
Trend over the years
In euros
In per cent
Ratio
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.

Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the fiscal year before
favourable unfavourable
Line20242025
Operating result€60,827-€56,127▼ 7.7%
Net result€45,191within the sector's middle half-€43,042within the sector's middle half▼ 4.8%
Equity€50,191within the sector's middle half-€93,233within the sector's middle half▲ 85.8%
Total assets€294,834within the sector's middle half-€332,199within the sector's middle half▲ 12.7%
Debt€244,643-€238,966▼ 2.3%
Working capital-€151,241below the sector's middle half--€73,657below the sector's middle half▲ 51.3%
Solvency17.0%below the sector's middle half-28.1%below the sector's middle half▲ 11.0pp
Current ratio0.38below the sector's middle half-0.69below the sector's middle half▲ 0.31
Return on assets (ROA)15.3%within the sector's middle half-13.0%within the sector's middle half▼ 2.4pp
above within below the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result and balance sheet2025
Result per fiscal year
Operating resultNet result
€0€20,000€40,000€60,000Operating result 2024: €60,827€60,827Net result 2024: €45,191€45,191Operating result 2025: €56,127€56,127Net result 2025: €43,042€43,04220242025€0€20,000€40,000€60,000Operating result 2024: €60,827€60,800Net result 2024: €45,191€45,200Operating result 2025: €56,127€56,100Net result 2025: €43,042€43,00020242025
The operating result falls in 2025; 2025 is 8% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €332,199
Fixed assets €167,790 ▼ 16.7%
Current assets €164,409 ▲ 76.0%
Equity and liabilities €332,199
Equity €93,233 ▲ 85.8%
Debt €238,966 ▼ 2.3%
Debt's share of the balance-sheet total falls from 83.0% to 71.9%. Equity is higher and debt is lower.
Key figures and ratios2025
Key figures and ratios
2025 value · change against 2024
EBITDA
€86,090▼
2024 · €94,141
Cash flow
€73,005▼
2024 · €78,505
Debt to equity
2.56▼
2024 · 4.87
ROE
46.2%▼
2024 · 90.0%
Interest coverage
39.59▼
2024 · 264.19
Debt ≤ 1 year
€238,066▼
2024 · €244,643
Income taxes
€10,910▼
2024 · €15,280
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 7,976 companies that looked in July 2024 the way this one looks now, 3.6% went bankrupt within 24 months and 94% are still going.

  • Micro
  • 2 to 5 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more
3.6% went bankrupt
1.8% stopped otherwise
94% still going

A further 0.3% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: 0.2% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,341 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 7,976 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Filed annual accountsfiscal year 2025
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 38 lines
Balance sheet Code20242025
Assets
Total assets20/58€294,834€332,199▲
Fixed assets21/28€201,432€167,790▼
Intangible fixed assets21€134,083€118,852▼
Tangible fixed assets22/27€67,349€48,937▼
Plant, machinery and equipment23€6,727€1,788▼
Furniture and vehicles24€10,887€7,900▼
Other tangible fixed assets26€49,735€39,249▼
Current assets29/58€93,402€164,409▲
Amounts receivable within one year40/41-€14,620
Other amounts receivable41-€14,620
Cash at bank and in hand54/58€93,050€148,509▲
Deferred charges and accrued income490/1€352€1,280▲
Equity and liabilities
Total equity and liabilities10/49€294,834€332,199▲
Equity10/15€50,191€93,233▲
Contributions10/11€5,000€5,000=
Profit (loss) carried forward14€45,191€88,233▲
Amounts payable17/49€244,643€238,966▼
Amounts payable within one year42/48€244,643€238,066▼
Trade debts44€5,342€961▼
Suppliers440/4€5,342€961▼
Taxes, remuneration and social security45€15,280€26,190▲
Taxes450/3€15,280€26,190▲
Other amounts payable47/48€224,021€210,915▼
Accrued charges and deferred income492/3-€900
Income statement Code20242025
Non-recurring operating income76A-€1,942
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€33,314€29,963▼
Other operating charges640/8€1,619€1,668▲
Non-recurring operating charges66A-€203
Gross operating margin9900€95,760€87,961▼
Operating profit (loss)9901€60,827€56,127▼
Financial charges65/66B€356€2,175▲
Recurring financial charges65€356€2,175▲
Profit (loss) for the period before taxes9903€60,470€53,953▼
Income taxes67/77€15,280€10,910▼
Profit (loss) for the period9904€45,191€43,042▼
Profit (loss) for the period to be appropriated9905€45,191€43,042▼
Appropriation of the result
Profit (loss) to be appropriated9906€45,191€88,233▲
Profit (loss) brought forward from the previous period14P-€45,191

The notes to these accounts (13 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20242025Change
Non-recurring operating income76A-€1,942-
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€33,314€29,963▼ 10.1%
Other operating charges640/8€1,619€1,668▲ 3.0%
Non-recurring operating charges66A-€203-
Gross operating margin9900€95,760€87,961▼ 8.1%
Operating profit (loss)9901€60,827€56,127▼ 7.7%
Financial charges65/66B€356€2,175▲ 510%
Recurring financial charges65€356€2,175▲ 510%
Profit (loss) for the period before taxes9903€60,470€53,953▼ 10.8%
Income taxes67/77€15,280€10,910▼ 28.6%
Profit (loss) for the period9904€45,191€43,042▼ 4.8%
Profit (loss) for the period to be appropriated9905€45,191€43,042▼ 4.8%
Line20242025Change
Assets
Total assets20/58€294,834€332,199▲ 12.7%
Fixed assets21/28€201,432€167,790▼ 16.7%
Intangible fixed assets21€134,083€118,852▼ 11.4%
Tangible fixed assets22/27€67,349€48,937▼ 27.3%
Plant, machinery and equipment23€6,727€1,788▼ 73.4%
Furniture and vehicles24€10,887€7,900▼ 27.4%
Other tangible fixed assets26€49,735€39,249▼ 21.1%
Current assets29/58€93,402€164,409▲ 76.0%
Amounts receivable within one year40/41-€14,620-
Other amounts receivable41-€14,620-
Cash at bank and in hand54/58€93,050€148,509▲ 59.6%
Deferred charges and accrued income490/1€352€1,280▲ 264%
Equity and liabilities
Total equity and liabilities10/49€294,834€332,199▲ 12.7%
Equity10/15€50,191€93,233▲ 85.8%
Contributions10/11€5,000€5,000=
Profit (loss) carried forward14€45,191€88,233▲ 95.2%
Amounts payable17/49€244,643€238,966▼ 2.3%
Amounts payable within one year42/48€244,643€238,066▼ 2.7%
Trade debts44€5,342€961▼ 82.0%
Suppliers440/4€5,342€961▼ 82.0%
Taxes, remuneration and social security45€15,280€26,190▲ 71.4%
Taxes450/3€15,280€26,190▲ 71.4%
Other amounts payable47/48€224,021€210,915▼ 5.9%
Accrued charges and deferred income492/3-€900-
Line20242025Change
Profit (loss) for the period9904€45,191€43,042▼ 4.8%
+ Depreciation and write-downs630€33,314€29,963▼ 10.1%
Operating cash flow (approximation)€78,505€73,005▼ 7.0%
Investment in fixed assets (approximation)-€3,679-
Change in cash-€55,459-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Comparable companies5

Timeline

2 eventsLatest 31-08-2026Next filing 31-07-2027

History

On 21 November 2023, Dr. Imke Bytebier was incorporated as a Private limited company.1 The company has filed 2 sets of annual accounts, the latest for fiscal year 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2025

Acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
31-08
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 31 days late
2025
29-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 29 days late
NBB filing
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Support & recognitions

1 funding sourceFlanders €7,537
Flemish government
€7,537
awarded · 2025
Subsidies and aid1

Flemish government

2025 · 1 entry · €7,537 awarded · €7,537 paid
Year Entries awardedpaid
2025 1 €7,537€7,537
Schemes
1 entry · €7,537 · €7,537 paid · Departement Werk, Economie, Wetenschap, Innovatie en Sociale Economie

Company details

Private limited company · founded 21-11-2023Year ends 31-12Peppol reachable1 site

Register details

Identification
Legal formPrivate limited company
Founded21-11-2023
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
E-invoicing
Reachable via Peppol
Peppol ID 0208:1002495889
Also 9925:BE1002495889

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 1 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Sites & property

Location & real-estate footprint
Registered office, Boechout · 1 establishment unit since 2023
seat establishment The establishment unit on the map
Ground area
560 m²
Building footprint
165 m²
Volume, LiDAR
226 m³
Parcel 11047B0067/00L003, Flanders · tallest building 7.5 m. Linked by address, not a title deed.
3 companies at this address See who is registered here
1 establishment unit
Dr. Imke Bytebier
Vremdesesteenweg 261, 2531 BoechoutGeneral medical practice
since 2023unit no. 2.352.328.984
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
11047B0067/00L003 Flanders 560 m² 1 · 165 m² 7.5 m
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.